Methotrexate Sodium Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Methotrexate Sodium Injection (injection) from Hospira, Inc., A Pfizer Company with status Current. The shortage was first posted on Mar 13, 2023. Reported reason: Other
Shortage details
- Status
- Current
- Company
- Hospira, Inc., A Pfizer Company
- Package NDC
- 61703-161-05
- Dosage Form
- Injection
- Presentation
- Methotrexate Sodium, Injection, 50 mg/2 mL (25 mg/mL) Multiple Dose Vial PREMIERProRx (NDC 61703-161-05)
- Initial Posting
- Mar 13, 2023
Reason
Other